REQUEST A DEMO
Total
USD $0.00
Search more companies

Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. (Turkiye)

Main Activities: Kidney Dialysis Centers
Full name: Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. is a company in Turkiye, with a head office in Istanbul. It operates in the Kidney Dialysis Centers sector. It was first established on March 24, 2005. It currently has a total number of 51 (2022) employees. In 2020, the company reported a net sales revenue increase of 16.89%. Its total assets grew by 45.77% over the same period. The net profit margin of Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. increased by 7.84% in 2020.

Headquarters
No:44 Cevizli Mahallesi Cifteler Caddesi Kartal
Istanbul; Marmara; Postal Code: 34865

Contact Details: Purchase the Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. report to view the information.

Website: http://www.turkmeddiyaliz.com

Basic Information
Total Employees:
Purchase the Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. report to view the information.
Outstanding Shares:
Purchase the Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. report to view the information.
Incorporation Date:
March 24, 2005
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Turkmed Diyaliz Ve Bobrek Sagligi Kurumlari A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
16.89%
Total operating revenue
16.89%
Operating profit (EBIT)
102.08%
Net Profit (Loss) for the Period
445.88%
Total assets
45.77%
Total equity
364.26%
Operating Profit Margin (ROS)
6.31%
Net Profit Margin
7.84%
Return on Equity (ROE)
11.73%
Debt to Equity Ratio
-535.8%
Quick Ratio
-0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?